AccuPulse

Suzhou, China · Founded 2020 · Privately Held (backing)

Developer of a pulsed field ablation (PFA) system intended to treat Atrial fibrillation (A-fib). AccuPulse is based in Suzhou, China and was founded in 2020. It has raised $64.6 million.

Last price · $/share
—
Implied valuation
—
Total raised
$64.6M
Last round
—

Who backs AccuPulse?

10 investors
InvestorType
CICC CapitalPE / buyout
Qianhai FoFFund of funds
YuanBio Venture CapitalVenture capital
Leader Venture CapitalOther
Vision Plus CapitalVenture capital
Shanghai Healthcare CapitalPE / buyout
Beijing Shengshi Hongming Investment Fund Management—
Med-Fine Capital—
Nantong Blue Bay Ventures—
Ruizhengfu (Hainan) Private Equity Fund Management—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

AccuPulse investors

10 investors are on record for AccuPulse, including CICC Capital, Qianhai FoF, YuanBio Venture Capital and Leader Venture Capital. By type, the record holds 2 venture capital firms, 2 private equity firms and 1 fund of funds.

Free account
More of AccuPulse with a free account
  • ·Watch AccuPulse: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like AccuPulse. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View